Courage Therapeutics

Newton, United States

Courage Therapeutics is a research organization that develops new medicines for eating disorders.

$7.8M raised

May 2025

Seed

Biotechnology Health Care Medical Pharmaceutical

Top Investors

What If VenturesArsenal Bridge VenturesMichigan Biomedical Venture Fund

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Courage Therapeutics

How much funding has Courage Therapeutics raised?

Courage Therapeutics has raised $7.8M in total funding. The most recent round was Seed. The last funding was announced in May 2025.

Who are Courage Therapeutics's investors?

Courage Therapeutics's investors include What If Ventures, Arsenal Bridge Ventures, Michigan Biomedical Venture Fund.

Where is Courage Therapeutics headquartered?

Courage Therapeutics is headquartered in Newton, United States.

What does Courage Therapeutics do?

Courage Therapeutics is a research organization that develops new medicines for eating disorders.

What stage is Courage Therapeutics at?

Courage Therapeutics is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 16, 2025.

MLA

"Courage Therapeutics — Funding & Investors." VCBacked, May 16, 2025, https://www.vcbacked.co/company/courage-therapeutics. Accessed June 17, 2026.

APA

VCBacked. (2025). Courage Therapeutics — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/courage-therapeutics

Wikipedia (cite web)

{{cite web |title=Courage Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/courage-therapeutics |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 16, 2025.

Similar Companies in Biotechnology